Travasol 10% W/o Electrolytes

   
Google
 
Web NewDrugInformation.com

Travasol 10% W/o Electrolytes


Drug - Travasol 10% W/o Electrolytes
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Amino Acids
Multiple ingredients are in alphabetical order.

Strength - 10% (10GM/100ML)
The potency of the active ingredient(s), Amino Acids. May repeat for multiple part products.

Applicant - BAXTER HLTHCARE
The firm name holding legal responsibility for Travasol 10% W/o Electrolytes. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017493
The FDA assigned number to Travasol 10% W/o Electrolytes. Format is nnnnnn.

Product Number - 006
The FDA assigned number to identify Travasol 10% W/o Electrolytes. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Travasol 10% W/o Electrolytes was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Travasol 10% W/o Electrolytes. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Travasol 10% W/o Electrolytes is in. Format is RX, OTC, DISCN.

Applicant Full Name - Baxter Healthcare Corp
The full name of the firm holding legal responsibility for the new application of Travasol 10% W/o Electrolytes.

Travasol 10% W/o Electrolytes